Payment overview · 2025
General Payments
$35.27
2 reported records · 2 companies
Healthcare provider profile · identity verified
Mark A Snider, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MONROE, MI · NPI 1003815465
Verified facts
What the public records show
CMS Open Payments records show Mark A Snider, M.D. received $35.27 in general payments during 2025 across 2 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 56.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Linzess by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $19.85 | 56.3% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $15.42 | 43.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.27 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $19.85 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $15.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 41 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
41 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 902 | 124 |
| Atorvastatin Calcium | Atorvastatin Calcium | 710 | 114 |
| Amlodipine Besylate | Amlodipine Besylate | 651 | 91 |
| Furosemide | Furosemide | 468 | 72 |
| Gabapentin | Gabapentin | 454 | 61 |
| Lisinopril | Lisinopril | 422 | 65 |
| Eliquis | Apixaban | 407 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 361 | 70 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 340 | 62 |
| Donepezil Hcl | Donepezil Hcl | 321 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 269 | 48 |
| Carvedilol | Carvedilol | 247 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 245 | 44 |
| Metformin Hcl | Metformin Hcl | 239 | 46 |
| Potassium Chloride | Potassium Chloride | 238 | 42 |
| Tramadol Hcl | Tramadol Hcl | 229 | 39 |
| Omeprazole | Omeprazole | 227 | 62 |
| Simvastatin | Simvastatin | 211 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 209 | 37 |
| Sertraline Hcl | Sertraline Hcl | 196 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 190 | 27 |
| Losartan Potassium | Losartan Potassium | 175 | 29 |
| Alprazolam | Alprazolam | 171 | 37 |
| Atenolol | Atenolol | 160 | 24 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 157 | 19 |
| Trazodone Hcl | Trazodone Hcl | 155 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 21 |
| Lidocaine | Lidocaine | 145 | suppressed |
| Famotidine | Famotidine | 142 | 34 |
| Mirtazapine | Mirtazapine | 134 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 133 | 16 |
| Lorazepam | Lorazepam | 129 | 25 |
| Meloxicam | Meloxicam | 123 | 21 |
| Myrbetriq | Mirabegron | 122 | 12 |
| Memantine Hcl | Memantine Hcl | 121 | 14 |
| Bumetanide | Bumetanide | 109 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 107 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 102 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 98 | 26 |
| Prednisone | Prednisone | 94 | 28 |
| Alendronate Sodium | Alendronate Sodium | 85 | 13 |
| Montelukast Sodium | Montelukast Sodium | 85 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 84 | 14 |
| Buspirone Hcl | Buspirone Hcl | 82 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 82 | 14 |
| Latanoprost | Latanoprost | 82 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 82 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 81 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 80 | 13 |
| Spironolactone | Spironolactone | 78 | 19 |
| Clonazepam | Clonazepam | 77 | suppressed |
| Nystatin | Nystatin | 76 | 36 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 74 | 37 |
| Warfarin Sodium | Warfarin Sodium | 70 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 20 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 64 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 62 | 11 |
| Amoxicillin | Amoxicillin | 61 | 24 |
| Risperidone | Risperidone | 60 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 60 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 58 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 57 | suppressed |
| Baclofen | Baclofen | 56 | suppressed |
| Celecoxib | Celecoxib | 54 | 11 |
| Ibuprofen | Ibuprofen | 54 | 14 |
| Levetiracetam | Levetiracetam | 54 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 53 | 41 |
| Ozempic | Semaglutide | 53 | suppressed |
| Sucralfate | Sucralfate | 53 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 52 | 21 |
| Azithromycin | Azithromycin | 52 | 34 |
| Dicyclomine Hcl | Dicyclomine Hcl | 52 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 52 | suppressed |
| Gemtesa | Vibegron | 50 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 49 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 48 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 46 | suppressed |
| Glipizide | Glipizide | 46 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 46 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | suppressed |
| Levofloxacin | Levofloxacin | 44 | 29 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Budesonide | Budesonide | 43 | suppressed |
| Entresto | Sacubitril/Valsartan | 43 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 42 | 30 |
| Temazepam | Temazepam | 42 | suppressed |
| Lamotrigine | Lamotrigine | 41 | suppressed |
| Mupirocin | Mupirocin | 41 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 28 |
| Rexulti | Brexpiprazole | 41 | suppressed |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Diazepam | Diazepam | 39 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | suppressed |
| Allopurinol | Allopurinol | 38 | 14 |
| Ramipril | Ramipril | 38 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 37 | suppressed |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 36 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | 13 |
| Lagevrio (Eua) | Molnupiravir | 35 | 34 |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 34 | suppressed |
| Finasteride | Finasteride | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | suppressed |
| Acyclovir | Acyclovir | 32 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 32 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 31 | 15 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 11 |
| Cephalexin | Cephalexin | 28 | 22 |
| Colestipol Hcl | Colestipol Hcl | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 11 |
| Linzess | Linaclotide | 28 | suppressed |
| Acetazolamide | Acetazolamide | 27 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Armodafinil | Armodafinil | 26 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 26 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 26 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 25 | suppressed |
| Sotalol | Sotalol Hcl | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Jardiance | Empagliflozin | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 24 | suppressed |
| Restasis | Cyclosporine | 24 | suppressed |
| Brilinta | Ticagrelor | 23 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Anastrozole | Anastrozole | 22 | suppressed |
| Mirabegron Er | Mirabegron | 22 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 21 | 20 |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Methimazole | Methimazole | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Prevalite | Cholestyramine | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 16 | suppressed |
| Mesalamine | Mesalamine | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Tobramycin | Tobramycin | 16 | 13 |
| Arnuity Ellipta | Fluticasone Furoate | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 15 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Nystop | Nystatin | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Desloratadine | Desloratadine | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Methazolamide | Methazolamide | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.27 · 2 records | Otsuka America Pharmaceutical, Inc. | REXULTI, UBRELVY | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error